Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
721 to 740 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Vitro Evaluation of Anti-Rotaviral Activity and Intestinal Toxicity of a Phytotherapeutic Prototype of Achyrocline bogotensis (Kunth) DC. | Viruses | 2022 | 36366492 | PubTator, text mining | PubMed |
| A Review of Potential Therapeutic Strategies for COVID-19. | Viruses | 2022 | 36366444 | PubTator, text mining | PubMed |
| Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses. | Vaccines (Basel) | 2022 | 36366313 | PubTator, text mining | PubMed |
| Current Treatments for COVID-19: Application of Supercritical Fluids in the Manufacturing of Oral and Pulmonary Formulations. | Pharmaceutics | 2022 | 36365198 | PubTator, text mining | PubMed |
| Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update. | Int J Mol Sci | 2022 | 36362351 | PubTator, text mining | PubMed |
| Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand? | Biomedicines | 2022 | 36359334 | PubTator, text mining | PubMed |
| Genome Analysis of the G6P6 Genotype of Porcine Group C Rotavirus in China. | Animals (Basel) | 2022 | 36359075 | PubTator, text mining | PubMed |
| Early detection of emerging SARS-CoV-2 variants of interest for experimental evaluation. | Front Bioinform | 2022 | 36353215 | PubTator, text mining | PubMed |
| Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals. | Front Chem | 2022 | 36353143 | PubTator, text mining | PubMed |
| Could nucleocapsid be a next-generation COVID-19 vaccine candidate? | Int J Infect Dis | 2022 | 36347459 | PubTator, text mining | PubMed |
| A mechanism for SARS-CoV-2 RNA capping and its inhibition by nucleotide analog inhibitors. | Cell | 2022 | 36335936 | PubTator, text mining | PubMed |
| Unmasking the Conformational Stability and Inhibitor Binding to SARS-CoV-2 Main Protease Active Site Mutants and Miniprecursor. | J Mol Biol | 2022 | 36334779 | PubTator, text mining | PubMed |
| SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia. | Redox Biol | 2022 | 36334378 | PubTator, text mining | PubMed |
| SARS-CoV-2 quasi-species analysis from patients with persistent nasopharyngeal shedding. | Sci Rep | 2022 | 36333340 | PubTator, text mining | PubMed |
| Rational design of the zonulin inhibitor AT1001 derivatives as potential anti SARS-CoV-2. | Eur J Med Chem | 2022 | 36332548 | PubTator, text mining | PubMed |
| Investigation of SARS-CoV-2 lineages and mutations circulating in a university-affiliated hospital in South Korea analyzed using Oxford Nanopore MinION sequencing. | Osong Public Health Res Perspect | 2022 | 36328240 | PubTator, text mining | PubMed |
| Laboratory Considerations for Reporting Cycle Threshold Value in COVID-19. | EJIFCC | 2022 | 36313906 | PubTator, text mining | PubMed |
| SARS-CoV-2 Mutations Responsible for Immune Evasion Leading to Breakthrough Infection. | Cureus | 2022 | 36312656 | PubTator, text mining | PubMed |
| Discovery of host-directed modulators of virus infection by probing the SARS-CoV-2-host protein-protein interaction network. | Brief Bioinform | 2022 | 36305426 | PubTator, text mining | PubMed |
| Discovery of putative inhibitors against main drivers of SARS-CoV-2 infection: Insight from quantum mechanical evaluation and molecular modeling. | Front Chem | 2022 | 36304744 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=37